• IONIC Brands recently expressed its position and concerns in the wake of a nationwide health scare involving vape-related illnesses that have sickened hundreds and killed more than a dozen people
• The U.S. Centers for Disease Control and Prevention has acknowledged that it believes cannabis vapes purchased on the black market are the primary source of the illness cases
• IONIC Brands emphasized in a news release that it abides by applicable laws in states where it operates and that it doesn’t use additives that have become the focus of health officials’ investigation into vaping products
• The company temporarily stopped production in California, citing concerns about insufficient regulation of black market vape products that do contain potentially harmful additives

As concerns about the safety of vaping products have swept the nation without a clear explanation of what is causing vape-related illnesses, vape manufacturers have found themselves searching for answers, much like the consumers who enjoy their products. On September 27, the U.S. Centers for Disease Control and Prevention acknowledged that the vast majority of the reported vape-related illnesses are linked to cannabis products purchased on the black market instead of from reputable, law-abiding businesses (http://ibn.fm/4QyqJ).

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) addressed the vaporizer concerns in a news release issued September 26, noting the company’s safety standards, its adherence to applicable laws and its desires for a stronger response to black market operations.

“This is not a cannabis issue. This is an illicit market issue that calls for more regulation, not less,” CEO and Chairman John Gorst stated in the news release (http://ibn.fm/q8W5J). “We are aware of the pervasive dangers of black-market operators infiltrating legal markets with counterfeit, illegal and unregulated products. We strongly advise consumers to never use black market or illegal products, and to choose only tested and compliant products from licensed dispensaries.”

Gorst wrote that the health scare and the proliferation of black-market products in California has led the company to temporarily suspend production there in the world’s largest cannabis market until state regulators show a greater capacity to enforce the laws of the state.

“We are specifically concerned with the proliferation of these illegal and unregulated black-market products in California,” Gorst added. “We feel that it is too great a risk to our customers and shareholders and brands to continue production in California until regulators can take control of this problem.”

The CDC’s report was a response to various officials who have blamed flavored nicotine products in e-cigarettes for the illnesses. The report states that, as of September 27, 806 people in 46 states had become sick and 13 had died as an apparent result of the vape crisis, but only 16 percent of those sickened said they only used nicotine, leaving health officials to question whether some of the ill simply don’t want to acknowledge that they were using black market cannabis.

Marijuana media agency Leafly reported that same week that as many as 50 million cannabis cartridges could be tainted with lead, pesticides or residual solvent butane, with a particular focus on vitamin E acetate, which has reportedly become a favored oil used to cut the cannabis oil content and improve profits for black market operators (http://ibn.fm/Qf1R2).

“All of our products are created using only the highest quality materials exclusively sourced from licensed producers of integrity, that use state of the art equipment, and ensure strict operating practices and procedures are followed. We have never and will never use any additives that contain vitamin E acetate, or any additives that are based on petrochemicals,” Gorst stated in the IONIC Brands news release.

While health officials and regulators continue to examine the situation, IONIC Brands hasn’t stopped developing its premium and luxury consumer portfolio according to the laws of the states in which it operates, and it is preparing to launch the first Bluetooth-enabled vaporizer and platform specifically designed for cannabis use within the next few weeks in an effort to further ensure safety through controlled dosing.

The company has six cannabis product lines in its stable, presented in three mood offerings for recreational use – rich sociability, serene relaxation and enlightened creativity (http://ibn.fm/CNtUB).

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://ibn.fm/IONKF

• Wildflower Brands is working hard to establish a solid retail network in the U.S. and Canada
• The company has achieved a number of strategic partnerships and acquisitions, making Wildflower Brands wellness products available in 600 locations across America
• The company also operates four premier cannabis locations in British Columbia under its subsidiary, City Cannabis Corp.

The global hemp-derived CBD oil market reached $591 million in 2018 and is anticipated to grow to $22 billion by 2022 (http://ibn.fm/yPoHn). Wellness and health products are expected to drive this growth as awareness about the benefits of CBD oil continues to increase.

CBD oil was first highlighted in the early 2010s, when reports emerged of it being used in the treatment of children with epilepsy. Since then, multiple additional health benefits have been researched and confirmed. CBD oil has taken off commercially, especially after the passage of the federal Farm Bill. The changing legislative framework has made it much easier to grow hemp and to extract the valuable resource from it. Today, CBD oil is being added to beverages, edibles, topical creams, oils, waxes and pills.

Companies like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) are working hard to establish their CBD market leadership amid this popularity boom. A cannabis company focused on the development and design of branded products in the sector, Wildflower is focused on growing its retail distribution network throughout Canada and the U.S. Recently, the company completed a strategic acquisition of City Cannabis Corp., which will give it access to four retail cannabis stores in Vancouver, British Columbia, two of which were opened in August 2019 (http://ibn.fm/fIf56).

Simultaneously, Wildflower Brands is actively seeking opportunities to maximize its retail presence in the U.S. Its wellness products have been launched in over 260 Dillard’s department stores throughout the country (http://ibn.fm/GejdN). The initial purchase order is significant, because it enables Wildflower products to enter several new states, according to Wildflower CEO William McLean.

Earlier in 2019, Wildflower Brands launched a CBD-infused product collaboration with wellness guru Joel Warren, making the products available at Warren’s Saks Fifth Avenue salon (http://ibn.fm/Erjn8). In addition, the company initiated a strategic New York expansion that made the products available at 20 premium health and wellness stores throughout Manhattan.

Following the latest strategic partnerships and retail collaborations, the Wildflower Brands CBD-infused products can now be found in 600 locations across America.

The marketplace is forecast to explode in the near future, and the entities that have an already well-established and recognizable brand will benefit the most, as McLean stated in a news release. “Our strategy is to build off our established brand equity in these key markets and partner with brands that can catapult us into becoming a household name,” he concluded.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• Hemp biomass production is anticipated to continue to increase due to legislative changes and the growing demand for CBD products
• At the same time, the industry is experiencing an extraction bottleneck due to the limited industry capacity for efficient biomass processing
• With its proprietary hemp biomass extraction technology that reduces operating costs while delivering superior results, HTC Extraction Systems is uniquely positioned to take advantage of upcoming market opportunities

Legislative changes and a rapidly increasing demand for CBD products paint a highly optimistic picture for hemp biomass production and extraction companies. Currently, the demand for hemp biomass is exceptionally high, and it is anticipated to remain at such levels through the end of 2019 and into the year to come, reports suggest (http://ibn.fm/HoOoL).

The trend started with the passage of the Federal Farm Bill at the end of 2018. This new regulatory framework enabled the legal growth of hemp and also boosted interest in products derived from hemp biomass. In 2018, industrial hemp cultivation started growing exponentially (http://ibn.fm/CCfFq). Farmers cultivated three times as many acres of hemp during that year as compared to 2017. Legal hemp cultivation reached 78,000 acres, marking a massive increase from approximately 10,000 acres in 2016.

Even more pronounced growth is anticipated in the years to come, with the hemp-derived CBD market being set to reach a volume of $22 billion by 2022. This market expansion has already begun, and higher product demand requires proven extraction and purification technologies.

At the same time, the hemp biomass processing power of the market is limited. The industry is experiencing a bottleneck due to the fact that, until present, hemp post-harvest processing facilities were a somewhat neglected part of the supply chain. Since the hemp biomass processing industry is still young and growing, many entities lack the equipment needed to scale up effectively and quickly.

Such market dynamics and forecasts for the future create opportunities for well-positioned hemp biomass processing entities like HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems has developed a proprietary biomass processing methodology. The process occurs in three stages – pre-oil preparation, oil extraction and purification and oil refinement. The result of this technology is 50 percent crude CBD oil that can be subjected to further distillation to produce full spectrum oil and/or pure CBD isolate.

The company has signed numerous strategic agreements that maximize its hemp biomass processing potential. Recently, HTC announced its entry into an identity preserved (“IDP”) hemp biomass production tolling agreement. The agreement covers 4,200 to 5,000 acres of hemp in Saskatchewan, Canada. Based on the agreement, HTC will process five million kilograms of IDP hemp biomass to produce full spectrum oil and/or pure CBD isolate.

The company is in negotiations for an additional 5,000 acres for the 2019 crop and up to 30,000 acres IDP hemp production for the 2020 crop.

HTC Extraction Systems develops proprietary extraction and purification systems. The company’s proprietary technologies are engineered to large-scale to reduce capital and operating costs while delivering superior performance.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• Wildflower Brands is focused on being a global supplier of CBD products for wellness and health
• The company now distributes in over 600 locations in the United States alone, and it recently signed an agreement with a firm in Poland to enter the European Union marketplace
• The company’s online sales have increased by more than 300 percent since 2018 and are growing by 40 percent from month to month

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a cannabis company that develops cannabis-based brands and products for health and wellness. This company’s goal is concerned with the manufacturing, distribution, marketing and retail of CBD products, as well as research and development of new and innovative products so as to produce a global wellness brand. The demand for cannabis-based products is expected to increase in the coming years, with profits predicted to soar in the future; this is a trend that is already evident in North America and Europe. In fact, the CBD market is projected to reach about $22 billion by the year 2020. The market for cannabis-based products is expected to increase in the future as CBD becomes more popular and legislation changes, allowing further expansion into the marketplace and enabling more products to become available for retail.

Wildflower Brands has an impressive distribution system in the United States, with more than 20 retailers in New York City and more than 200 retailers in Washington State. Currently, the company distributes its products in over 600 locations across the United States. Part of the reason for this sizable distribution network is the company’s agreement with the well-known and nationwide Dillard’s department store chain, which positions Dillard’s as a distributor for certain Wildflower Brands products.

Wildflower Brands is a leading cannabis product supplier, showing record profits. The company had revenue of $1.8 million at the end of March 2019 and has shown increasing revenue and profits for the last nine consecutive quarters. Wildflower Brands has increased its online product sales by over 300 percent since early 2018. The online sales have grown by 40 percent from month to month.

Notably, Wildflower Brands has also reached an agreement with Free People to sell its CBD products online (http://ibn.fm/ZsB8V).

The company has grown to span various entities, including Wildflower Wellness, Kings Extract and Exclusive. These entities enabled the further expansion of Wildflower Brands products into new markets and increased the distribution capability of the company. Wildflower Brands has also formed a partnership with Retail Worx to further facilitate the retail of CBD products within New York City. Wildflower Brands has also opened up two locations in British Columbia, Canada (http://ibn.fm/Hnmqi). These locations fall under subsidiary City Cannabis Corp. Wildflower Brands Inc. expects to expand further into the Canadian marketplace in the near future, with increasing revenue and profits forecast.

Wildflower Brands is keen on expansion into the global marketplace with a view toward moving into the regions of the world where CBD products are not as legally restricted in terms of sales and distribution. An agreement has been signed to enter the European Union marketplace by way of Poland. The agreement with Polish firm Two Towers was signed in April 2019. Wildflower Brands Inc. has plans for further expansion and distribution into the Asian marketplace in the near future.

The company has expanded tremendously since first being founded in 2012 as a private company. It became a public company in 2014, and, since then, the company has increased in prominence and achieved rising profits. It is not surprising that Wildflower Brands is doing well, considering the steps the company takes in partnering with other businesses and the steps it takes to move into and invest in new distribution hubs and markets around the world.

William MacLean, CEO of the company, also attributes much of the success of Wildflower Brands to the team it has assembled, with individuals who have the know-how to successfully achieve licensing and establish the brand in locations that are most likely to be successful in the long term. As a result, the company has 14 licenses for cannabis in the state of California. These licenses include the cultivation of medical and recreational cannabis, as well as the manufacturing, distribution and retail of such products. Wildflower Brands is uniquely positioned to be one of the top brands for cannabis-based products in the future.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at  http://ibn.fm/WLDFF

• Pressure BioSciences was described as an integral part of women’s cancer research efforts during a presentation last month at the International Gynecologic Cancer Society conference in Brazil
• The company’s patented pressure cycling technology provided a key link in a trio of procedures for analyzing biopsied cells
• Gynecologic cancers are diagnosed in the United States at a rate of nearly 100,000 women per year, and the global gynecological cancer drug market is expected to generate revenues of more than $41.8 billion by 2026

A new, novel workflow for the analysis of proteins from cancer biopsy samples was recently disclosed at a major international gynecologic cancer meeting. This innovative workflow is expected to markedly enhance cancer diagnosis, prognosis and effective treatment therapies. The revelation of this new workflow has augmented the reputation of Pressure BioSciences Inc. (OTCQB: PBIO) amid the modern science rush to build better precision medicine for malignancies that claim hundreds of thousands of lives each year in the United States alone (http://ibn.fm/vawZS).

Human biology is complex, but scientific advances in the field of big data analysis have provided remarkably advanced tools for attempting repairs on the constellation of minuscule pieces of the human machine that may break down.

Efforts to develop an optimal means of analyzing proteins from cancer biopsy samples led one group of top gynecologic researchers to a new, innovative workflow that utilizes Pressure BioSciences’ patented pressure cycling technology (PCT) platform as the bridging mechanism in a process that begins with Leica Microsystems’ laser microdissection (LMD) platform and ends with comprehensive analysis on a ThermoFisher Scientific mass spectrometry (MS) instrument.

Pressure BioSciences’ PCT platform, as an integral part of the analytical trio, prepares the excised cells for micro-scale quantitative proteomics and phosphoproteomics – the large-scale study of proteins and their phosphorylation-based signaling networks – by provoking rapid and efficient high-quality cellular protein release and preparation from the biopsy samples. The entire sample preparation process is done in the company’s proprietary Barocycler 2320EXT system.

The researchers presented an explanation of their working process in searching for ways to combat gynecological cancers during a core session of the annual International Gynecologic Cancer Society (“IGCS”) conference last month in Rio de Janeiro, Brazil. Dr. Larry Maxwell, a gynecologic oncologist and the OB-GYN chairman at Northern Virginia’s Inova Fairfax Hospital, described the PCT-based Barocycler system technology provided by Pressure BioSciences as “an essential requirement for our novel workflow in meeting our goals” in his presentation to the IGCS.

“The conventional use of chemotherapy in ovarian cancer treatment is being rapidly replaced by biologic therapeutics that target the cancer (the ‘seed’) and also the micro-environment (the ‘soil’) in which it grows,” Maxwell stated in a news release (http://ibn.fm/fo6x7). “Being able to collect small tissue specimens and characterize them across multiple genomic and proteomic platforms will enable us to markedly enhance our ability to develop companion diagnostics and prognostics as well as identify targets for future therapeutic strategies.”

Protein chemist Dr. Thomas Conrads, the senior director of women’s health research at the Inova Women’s Hospital, added, “We believe that the insights we gain from applying this novel workflow will result in significant improvements in the clinical management of gynecologic cancer.”

Gynecologic cancers are diagnosed at a rate of nearly 100,000 women per year in the United States (http://ibn.fm/koVZR). Aurora Healthcare estimates that more than 30,000 of those patients die each year (http://ibn.fm/EezJZ). Publication The Pharma Letter, citing analysis by Persistence Market Research Report, states that the worldwide market for gynecological cancer drugs is expected to expand at a CAGR of 6.2 percent between 2018 and 2026, generating revenues of more than $41.8 billion (http://ibn.fm/aeE8t), with most of the costs led by the United States. The importance of effective therapies in terms of life-saving measures and product costs is apparent, and it serves as an indicator of PBIO technology’s potential attractiveness to other research labs.

Pressure BioSciences continues adding a number of significant achievements to underscore the reputation of its technology. Recently, the company announced an agreement with a world-renowned, multibillion-dollar biotherapeutics firm that will use PBIO’s proprietary BaroFold(TM) technology to improve the manufacture of a protein drug (http://ibn.fm/KaqJ1). Protein-based therapeutics are a growing part of the global health care industry, which is projected to reach nearly $249 billion in revenues by next year, according to Research and Markets analysis (http://ibn.fm/RIKAI).

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• The Pinnacle Combat Fight Group made its B2 Fighting Series fall season debut with nine amateur and three professional fights
• HRMMA Fight Group CEO and Founder Vanessa Higdon received an important award recognizing her contribution to MMA’s development; HRMMA is one of the key brands under the B2Digital umbrella
• As part of its growth strategy, B2Digital plans to continue developing and acquiring MMA and sports-related brands to ensure full vertical integration

B2Digital Inc. (OTC: BTDG), a full-service live events sports company, announced a couple of exciting new developments in late September and the beginning of October 2019. The company issued an update regarding its B2 Fighting Series fall season, which began with Colosseum Combat 50 in Kokomo, Indiana, on September 14. The season continued with the Pinnacle Combat Fight Group’s debut on September 28 (http://ibn.fm/84nSk).

The second event of the B2 Fighting Series, Pinnacle Combat Fight Group made its debut at McGrath Dubuque Harley Davidson in Dubuque, Iowa, with nine amateur and three professional fights and a professional flyweight headliner between Jeff Jepsen and Nathan Williams.

The B2 Fighting Series fall schedule, consisting of 10 live MMA fights in 10 different states, will continue with the HRMMA Fight Group event in Covington/Cincinnati, Ohio, on October 12.

The HRMMA event comes after the group’s founder and CEO, retired mixed martial arts fighter Vanessa Higdon, was honored with the 2019 Danny Davis Lifetime Achievement Award by the Kentucky Boxing and Wrestling Commission, according to a B2Digital press release (http://ibn.fm/IjzdP).

The award recognizes individuals who have outstanding accomplishments in Kentucky’s combat sports field. There have been multiple renowned previous winners, including Muhammad Ali (awarded posthumously).

Higdon initiated her MMA career in 2003, when she started working with other fight groups to promote the business aspect of live events. In 2006, Higdon became an MMA fighter who competed in several events until her retirement in 2008. In 2017, HRMMA became part of the B2Digital B2 Fighting Series.

Over the course of 11 years, Higdon executed 110 live MMA events. Her skills, experience and industry know-how position her as a crucial B2Digital executive team member. “Vanessa is one of the top CEOs in the MMA industry and it was a proud moment to watch her win this Lifetime Achievement Award. She does an excellent job operating HRMMA and developing MMA in her area. This is one of the most exciting parts of leading B2Digital – to work alongside and mentor Vanessa and the up-and-coming CEOs in the B2 Fighting Series,” B2Digital CEO and Chairman Greg P. Bell said in a news release.

B2Digital applies its extensive background in entertainment, television and video to the live sports events field. The company also capitalizes on its strong management team and hands-on experience to develop and acquire MMA and sports-related brands. Its ultimate goal is to build an integrated premier development league, initially focused on the billion-dollar MMA marketplace.

As a part of its growth strategy, B2Digital intends to continue developing and acquiring assets that fall in line with the company’s business model. Such acquisitions are expected to enable B2Digital to become a fully vertically integrated live event sports company.

For more information, visit the company’s website at www.B2DigitalOTC.com

NOTE TO INVESTORS: The latest news and updates relating to BTDG are available in the company’s newsroom at http://ibn.fm/BTDG

• ETST’s Hygee(TM) home testing kit for STIs helps women discreetly detect diseases
• The CDC estimates that there are 20 million new STI cases each year

As sexually transmitted infections (STIs) are reaching epidemic proportions worldwide, especially in remote regions with limited access to health care, men and women are searching for tools to take control of their sexual health. Earth Science Tech Inc. (OTCQB: ETST), a diverse biotech company focused on the nutraceutical and pharmaceutical fields, has developed the revolutionary Hygee(TM) home testing kit that allows women to screen for STIs like chlamydia and gonorrhea from the comfort of their own homes.

STI is an umbrella term encompassing 35 infectious organisms that are transmitted primarily through sexual activity (http://ibn.fm/6AFTz). The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 20 million new STD infections each year. Furthermore, the CDC estimates that undiagnosed and untreated STDs cause infertility in some 24,000 women in the U.S. each year. This creates an unmet demand for a discreet in-home screening tool like Hygee, which looks like – and is worn like – a standard panty liner.

“The best way to fight STIs is prevention, and the only way for women to avoid the dangerous results of untreated STI, is early treatment,” ETST CEO and Chief Science Officer Dr. Michel Aubé stated in a news release (http://ibn.fm/qUHno). “This means that women need to know if they are infected. We believe that Hygee(TM) will be the best tool to provide that information.”

Currently, most cases of STIs remain undiagnosed and untreated, posing a danger to pregnant women and their unborn babies. Results may include infertility in women and blindness or stillborn death in infants (http://ibn.fm/sjvOC). Not only does ETST provide a private screening tool, it also provides access to treatment recommendations through its partner testing lab.

Through Hygee, ETST offers the utmost in privacy for women suspecting that they may have an STI, which could be a key factor in decreasing the number of infections that remain undiagnosed each year. While many women may fear the stigma of being diagnosed with an STI, Hygee addresses that problem. The kit is for home use and conducted anonymously. Results are transferred through the mail, and women can read their lab results in private. By enabling more women around the world to have access to an easy, private screening tool, it may be possible to stem the flood of STIs globally.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• SRAX presented at the 5th Annual B. Riley Consumer & Media Conference
• CEO and Founder Christopher Miglino discussed the company’s impressive growth and upcoming initiatives during a NetworkNewsWire interview
• BIGtoken offers consumers control of and compensation for data

Digital marketing and consumer data management technology company SRAX Inc. (NASDAQ: SRAX) showcased its presentation yesterday at the 5th Annual B. Riley Consumer & Media Conference at the Sofitel Hotel in New York City (http://ibn.fm/OlIGi). CEO and Founder Christopher Miglino also met with investors and participated in a fireside chat with analyst Mike Crawford during the premier event.

SRAX is expanding its revenue streams by monetizing its datasets through various platforms. SRAX CEO and Founder Christopher Miglino joined Stuart Smith from NetworkNewsWire on September 19, 2019, for an audio interview reviewing the company’s impressive growth pattern during the past year and discussing future plans (http://ibn.fm/VKK4x).

“Our goal is to build the most valuable opted-in data set in the world,” Miglino stated in the interview. “We’ll have more consumers that have opted in to let us sell access to their data than any other company, and that’s invaluable.”

Miglino further stated that, as consumers realize the value potential of data, they are retaining their information. Privacy concerns are high, with governments passing laws that control the amount of data that website publishers such as Facebook, Twitter and Snapchat can access. SRAX provides companies with a secured privacy solution through the BIGtoken platform. SRAX has also teamed up with several high-profile nonprofit associations so that BIGtoken can contribute their earnings.

Developed by SRAX, BIGtoken can be downloaded from both the App Store and Google Play. The platform boasts over 16 million BIGtoken registered users worldwide and provides consumers with a safe and transparent environment for optimization and monetization of their data (http://ibn.fm/p4vn5). In exchange for giving brands access to their data by answering surveys, checking into locations, referring friends and more, BIGtoken users are rewarded with points, which they can then redeem for cash or gift cards.

SRAX works across many industry verticals and uses its technology to identify target consumers for brands and companies in the CPG, automotive, investor relations, luxury and lifestyle industries. By integrating data using verified consumer participation, the company provides useful insights to its client brands to keep those brands ahead of the competitive curve.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• HTC Extraction Systems has developed a proprietary ethanol-based distillation system called the Delta Purification System®, which works with the company’s DeltaSolv™ technologies
• The company published unaudited interim condensed consolidated financial results in August that show three-fold revenue gains over the previous year’s reporting period based on its ethanol, solvent and glycol reclamation operations
• HTC Extraction Systems is completing facilities in Saskatchewan for an identity preserved production, hemp biomass tolling and cannabidiol full-spectrum oil distillation operation

The proprietary ethanol, solvent and glycol reclamation operations of HTC Extraction Systems (TSX.V: HTC) granted the Saskatchewan, Canada-based company a three-fold increase in revenue during the past year, according to unaudited interim condensed consolidated financial results published August 28 (http://ibn.fm/EzRWR).

The condensed report, covering HTC Extraction Systems and its subsidiaries for the interim six-month period ended June 30, states that the company’s carbon dioxide extraction business and material handling operations drove revenues from $560,260 in 2018 to $1.85 million this year.

During that same period, the company’s total assets increased from $34.07 million to $35.29 million as HTC Extraction Systems built its strategy for extracting cannabidiol full-spectrum oil (“CBD FSO”) from hemp biomass for distillation. The company and its subsidiaries believe that their patented Delta Purification® System offers the best available environmental reclamation technology for the clean energy extraction and biomass extraction industries. HTC has finalized a hemp biomass tolling agreement that will result in the company processing an expected five million kilograms of identity preserved production hemp biomass, and it is completing negotiations to establish an identity preserved production hemp biomass tolling contract, with a 60,000-acre, recognized Canadian farm leader and significant hemp biomass producer, to extract the CBD FSO. The company then plans to use the tolling fee payable under the tolling contracts, in sales and offtake agreements with its related entity, Purely Canada Foods.

HTC Extraction Systems anticipates that, upon implementation of its intellectual property through its extraction and purification system, the hemp byproducts will be available for singulation and sale to the cannabinoid pharmaceutical market.

The unaudited interim condensed consolidated financial report also states that the company’s current liabilities decreased from $4.60 million in 2018 to $3.19 million this year, while long-term liabilities increased from $7.67 million last year to $8.69 million this year.

An increase in amortization of $914,805 over the previous year reflects the completion of building projects in 2018. The company has completed to exterior lock-up and is finalizing the interior of a 19,000-square-foot extraction tolling facility compliant with GMP Euro specifications. In addition, it is constructing a 27,000-square-foot facility for the storage and processing of pre-extraction biomass, located on six acres of land in Port Lajord, Saskatchewan, about 17 miles southeast of Regina – the province’s capital city and a cultural and commercial center for the southern part of the province.

The facility will include the Delta Purification® systems, distillation and refining equipment, with laboratory quality control and testing operations, utilizing the company’s trademarked DeltaSolv technologies that are custom-designed, ethanol-based solvent mixtures and additives optimized for efficient reclamation.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• ChineseInvestors.com offers first-rate financial information and innovative CBD products
• CBD is poised to become one of China’s largest industries over the next decade
• CIIX is at the vanguard of what may become the world’s largest CBD market

Offering an array of investor education products and services, ChineseInvestors.com Inc. (OTCQB: CIIX) provides web-based, real-time financial information in Chinese language character sets. Not only is it a top financial information website for Chinese-speaking investors in the U.S. and China, CIIX is also becoming a major player in the emerging CBD (cannabidiol) market for CBD-based nutrition and health products in China. The company is focusing back on its original mission of providing financial information and services to the larger Chinese community in the U.S. and globally while exploring major CDB market opportunities. As the disposable income of the average Chinese consumer continues to grow, CIIX is making moves to penetrate the steadily growing Chinese CBD market.

Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health care sector, which is expected to grow by as much as 10 percent per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.

CIIX developed its unique niche by concentrating on the Chinese-speaking markets where it has historically generated success. This bodes well for its CBD strategy. The company has created a three-year development plan to take advantage of mainland China’s interest in CBD-infused health and wellness products. Realizing that CBD is anticipated to become one of China’s largest industries over the next 10 years with a potential market of close to two billion people, CIIX’s strategy aims to educate consumers about the benefits of CBD oil.

CIIX is no stranger to the CBD market, as it operated one of the first Chinese-language CBD stores online. It also opened its initial CBD pop-up kiosk in Glendale Galleria Mall in California. This past February, CIIX launched its rebranded CBD consumer product line and consolidated its retail ecommerce outlets into a single site, www.365CWC.com. CIIX now offers consumers opt Hemp, which includes products infused with industrial hemp derived CDB. It additionally offers opt2mist(TM), a spray vitamin product line featuring full spectrum hemp-derived CBD-infused formulas.

CBD Biotech has its own product lines specifically designed for the Chinese market internationally. These include CBD Biotech’s Live Oxygen Series and its Magic Hemp Series.

The numbers show support for CIIX’s CBD-driven direction. Hemp and CBD sales were a key driver in its recent robust quarterly performance. For the third quarter of FY2019, ended February 28, 2019, CIIX reported total revenue of $1.4 million. This represents an increase of 81 percent from the same quarter of FY2018. Hemp and CBD sales increased almost 600 percent in Q3, reaching $1.1 million. Recently, CBD Biotech was a featured exhibitor at the Vietnam Expo, where it introduced its hemp-infused skincare line and hemp wine, which is expected to add to future sales growth.

CIIX continues to focus on investor education products and services and compelling CDB opportunities. The company offers investors the potential for portfolio gain because of its focus on highly diversified revenue streams. With its emphasis on premier financial information as well as high quality hemp-based CBD products, CIIX continues its march toward greater growth and profits for all its stakeholders.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX